Search clinical trials for: oral anti coagulant

Total 169929 results

Janssen Scientific Affairs, LLC
Bayer

Completed

A Study Exploring Two Strategies of Rivaroxaban (JNJ39039039; BAY-59-7939) and One of Oral Vitamin K Antagonist in Patients With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention (PIONEER AF-PCI)

Atrial Fibrillation | Percutaneous Coronary Intervention

United States, France, Poland, Ukraine, United Kingdom, Belgium, Germany, Taiwan, Argentina, Mexico, Bulgaria, Malaysia, Romania, Russian Federation, South Africa, Turkey, Korea, Republic of, Australia, Canada, Netherlands, Denmark and more
CNGE IRMG Association
University Hospital, Grenoble; Floralis

Completed

Comparison of Accidents and Their Circumstances With Oral Anticoagulants (CACAO)

Hemorrhagic Disorders | Embolism and Thrombosis | Cardiovascular Complications

France
University of Santiago de Compostela

Completed

Microbial Growth in the Suture Thread, After Application of Different Antiseptic Gels in Mandibular Third Molars Extraction

Bacterial Growth | Oral Surgery | Wisdom Teeth | Third Molar Surgery | Bioadhesive Gel | Suture Bacteria | Antiseptic Gel | Chistosan | Clorhexidine Gel Bacteria | Clorhexidine-chitosan
Medical University of Warsaw

Unknown

MultiCenter expeRience in AFib Patients Treated With OAC (CRAFT) (CRAFT)

Atrial Fibrillation

Poland
University of Sao Paulo

Completed

Safety of the Etonogestrel-releasing Implant During the Puerperium of Healthy Women

Contraception | Breastfeeding

Brazil
Sanofi

Completed

Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients (GetGoal-O)

Type 2 Diabetes

United States, Australia, Bulgaria, Canada, Denmark, Germany, Norway, Peru, Poland, South Africa, Spain, Sweden, United Kingdom
Novo Nordisk A/S

Completed

Comparison of Subject-driven Titration of Biphasic Insulin Aspart (BIAsp) 30 Twice Daily Versus Investigator-driven Titration of BIAsp 30 Twice Daily Both in Combination With Oral Antidiabetic Drugs in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

China
Georgetown University
Genentech, Inc.

Terminated

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A

Hemophilia A
Bayer
Janssen Research & Development, LLC

Completed

Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients

Pulmonary Embolism

Japan
Novo Nordisk A/S

Completed

Effect of Different Insulin Administrations, All in Combination With Metformin, on Glycaemic Control in Subjects With Type 2 Diabetes Inadequately Controlled by Oral Anti-diabetic Drugs

Diabetes Mellitus, Type 2 | Diabetes

Morocco, Tunisia, Algeria, South Africa, Egypt
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...

Completed

Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism

Venous Thromboembolism

United States, Canada, United Kingdom
Assistance Publique - Hôpitaux de Paris

Unknown

Benefit/Risk in Real Life of New Oral Anticoagulants and Vitamin K Antagonists in Patients Aged 75 Years and Over Suffering From Non Valvular Atrial Fibrillation (nv AF) (Presage-Aco)

Non Valvular Atrial Fibrillation (nv AF)
Baylor College of Medicine

Completed

Tranexamic Acid (TA) vs Combined Oral Contraceptive (COCP) Pilot Study

Menorrhagia

United States
Ain Shams University

Completed

Glucosamine as a Novel Adjunctive Therapy in Oral Lichen Planus

Oral Lichen Planus
University of Padova

Completed

Optimal Duration of Anticoagulation in Deep Venous Thrombosis (MORGAGNI)

Deep Vein Thrombosis of Lower Limb | Lower Extremity Deep Venous Thrombosis Recurrent

Italy
Bristol-Myers Squibb
University Hospital, Gentofte, Copenhagen

Completed

A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark

Anticoagulation

Denmark
Oakland University
Georgetown University

Completed

V2 Receptor Effects on Fluid Regulation and Performance

Hyponatremia | Hypernatremia | Electrolyte Imbalance

United States
The New England Baptist Hospital

Unknown

Non-inferiority Trial of Oral Tranexamic Acid vs. Intravenous Tranexamic Acid in Joint Replacement Surgery

Osteoarthritis | Blood Loss, Surgical | Blood Loss, Postoperative

United States
Otsuka Pharmaceutical Development & Commercialization...

Completed

International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia

Hyponatremia
Institut für Pharmakoökonomie und Arzneimittellogistik...

Completed

Stroke Prophylaxis of AF-patients: Real-life Effectiveness and Safety of Novel Anticoagulants Compared to VKA

Atrial Fibrillation | Stroke Prophylaxis
Ain Shams University

Unknown

Oral Tranexamic Acid Versus Diosmin for Treatment of Menorrhagia in Women Using Copper IUD

Menorrhagia

Egypt
Ferring Pharmaceuticals

Completed

Investigation of the Superiority Effect of Orally Disintegrating Desmopressin Tablets to Placebo in Terms of Night Voids Reduction in Nocturia Adult Male Patients

Nocturia

United States, Canada
National Cheng-Kung University Hospital
National Science Council, Taiwan

Completed

The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers (DDE)

Peptic Ulcer Bleeding

Taiwan
Fundació Institut de Recerca de l'Hospital de la...

Completed

Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding. (HEPACO)

Acute Gastrointestinal Bleeding

Spain
Bayer

Completed

Mirena or Conventional Medical Treatment for Menorrhagia

Menorrhagia

China, Indonesia, Korea, Republic of, Malaysia, Thailand, Taiwan, Hong Kong, Pakistan
St. Joseph's Healthcare Hamilton
McMaster University; University of Western Ontario, Canada

Completed

Does Low Dose Oral Vitamin K Improve International Normalized Ratio (INR) Stability? (OVWAC VII)

Thrombosis | Bleeding | Coagulation

Canada
Bayer
Janssen Research & Development, LLC

Completed

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion (X-VERT)

Atrial Fibrillation

Belgium, France, Spain, China, Italy, United States, Canada, South Africa, Portugal, Singapore, Germany, Greece, Netherlands, United Kingdom, Brazil, Denmark, Finland
Teva Women's Health

Completed

A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

Oral Contraceptive | Hemostasis

United States, Italy
Bayer

Completed

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women

Healthy

Germany
Green Cross Corporation
Parexel

Completed

A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers

Healthy Volunteers

United States
Tyumen State Medical Academy

Unknown

Hemocoagulation and Lipoperoxidation in Women Using Combined Oral Contraceptives, Correction by Antioxidants

Hyperandrogenism | Polycystic Ovarian Syndrome | Menstrual Irregularities

Russian Federation
Bayer

Completed

FC Patch Low: Metabolism Study

Contraception

Germany
Bayer

Completed

Management of Initial Bleeding/Spotting Associated With the Levonorgestrel-releasing Intrauterine System (MIRENA)

Uterine Hemorrhage

Ireland, Denmark, Norway
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Once-daily Oral Direct Factor Xa Inhibitor BAY59-7939 in Patients With Acute Symptomatic Deep-vein Thrombosis

Venous Thromboembolism

France, Italy, Czech Republic, Canada, Netherlands, Australia, United States, Poland, South Africa, Sweden, Israel, Denmark, Brazil
Boehringer Ingelheim

Completed

Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers

Healthy
Grupo de Estudos Multicentricos em Onco-Hematologia
Rio de Janeiro State Research Supporting Foundation (FAPERJ)

Unknown

Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients

Oral Hemorrhage

Brazil
Boehringer Ingelheim

Completed

Effects of BI 201335 NA on Cytochrome P450 and P-glycoprotein Activity Using a Probe Drug Cocktail in Healthy Volunteers

Healthy
Boehringer Ingelheim

Completed

Twice-daily Oral Direct Thrombin Inhibitor Dabigatran Etexilate in the Long Term Prevention of Recurrent Symptomatic VTE (RE-SONATE)

Venous Thromboembolism

United States, Australia, Austria, Belgium, Canada, Czech Republic, Estonia, Germany, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Russian Federation, Singapore, South Africa, Sweden, Switzer... and more
Cumberland Pharmaceuticals
Parke-Davis

Completed

Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia

Hyponatremia

Poland, United Kingdom, Germany, Spain, Belgium, France, Netherlands, Italy, Finland
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Pulmonary Embolism - The EINSTEIN PE Study

Pulmonary Embolism

United Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Switzerland, United States, New Zealand, Poland, India, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Estonia, Thailand, Brazil, Germany, Korea, Republic... and more
Bayer
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Completed

Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients With Acute Symptomatic Deep Vein Thrombosis - The EINSTEIN DVT Study

Venous Thrombosis

United Kingdom, Belgium, France, Israel, Italy, Spain, China, Hong Kong, Korea, Republic of, United States, New Zealand, Poland, India, Hungary, Singapore, Canada, Australia, Netherlands, Austria, Switzerland, Brazil, Denmark, Germany, Norw... and more
Fundació Institut de Recerca de l'Hospital de la...
Banc de Sang i Teixits

Completed

Fibrin Glue or Tranexamic Acid for Total Knee Arthroplasty (ATRHEMOS)

Knee Arthropathy

Spain
Icahn School of Medicine at Mount Sinai

Completed

Genetic Response to Warfarin in Healthy Subjects

Healthy

United States
Biosite

Completed

User Performance Evaluation of the INRatio® Prothrombin Time (PT) Monitoring System With a New INRatio Test Strip Designed for Low Sample Volume and Heparin Insensitivity (ECLIPSE-02)

Oral Anticoagulation

United States
Ferring Pharmaceuticals

Completed

A Study of Minirin Melt in Japanese Patients With Central Diabetes Insipidus (CDI).

Central Diabetes Insipidus

Japan
All India Institute of Medical Sciences, New Delhi
Indian Council of Medical Research

Unknown

Randomized Control Trial (RCT) of Transarterial Chemoembolization (TACE) Versus TACE and Oral Drug Therapy in the Treatment of Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

India
National Taiwan University Hospital

Unknown

Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic Hemostasis

Peptic Ulcers

Taiwan
Bayer

Completed

MiCo - Mirena or Conventional Medical Treatment for Menorrhagia

Idiopathic Menorrhagia

Croatia, South Africa, Colombia, Czech Republic, Jordan, Lebanon, Macedonia, The Former Yugoslav Republic of, Moldova, Republic of, Romania, Ukraine, Venezuela, Bosnia and Herzegovina, Syrian Arab Republic, Albania
Ferring Pharmaceuticals

Completed

Study With Two Different Doses of Desmopressin Orally Lyophilisate Tablet With Nocturnal Enuresis (PNE)

Nocturnal Enuresis

Japan
Rijnstate Hospital

Completed

LANN-study: Lantus, Amaryl, Novorapid, Novomix Study

Diabetes Mellitus Type II

Netherlands

Search clinical trials for: oral anti coagulant

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kosovo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations